Inventor · disambiguated record
Antoni Torrens Jover
Also filed as: TORRENS JOVER ANTONI
14 granted patents·10 pending applications·35 citations·filing 2003–2012
88Inventor score
Files withESTEVE LABOR DR14TORRENS JOVER ANTONI6ESTEVE LAB DR ESTEVE S A2BUSCHMANN HELMUT HEINRICH1GARCÍA LÓPEZ MÓNICA1
Top patents by PatentIndex Score
24 records- 0183US7345057B25-HT7 receptor antagonistsESTEVE LABOR DR·Filed 2005·Granted Mar 18, 2008·12 cites·31 claims
- 0276US8492425B25-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitorsTORRENS JOVER ANTONI·Filed 2009·Granted Jul 23, 2013·8 cites·8 claims
- 0374US8188115B25-HT7 receptor antagonistsTORRENS JOVER ANTONI·Filed 2005·Granted May 29, 2012·4 cites·10 claims
- 0474US7109349B2Process for obtaining Cizolirtine and its enantiomersESTEVE LABOR DR·Filed 2005·Granted Sep 19, 2006·2 cites·18 claims
- 0573US7078531B2Process for obtaining enantiomers of thienylazolylalcoxyethanaminesESTEVE LABOR DR·Filed 2005·Granted Jul 18, 2006·2 cites·20 claims
- 0673US6979742B1Process for obtaining enantiomers of thienylazolylalcoxyethanaminesESTEVE LABOR DR·Filed 2005·Granted Dec 27, 2005·2 cites·20 claims
- 0765US9518015B2EP1 receptor ligandsTORRENS JOVER ANTONI·Filed 2012·Granted Dec 13, 2016·3 cites·16 claims
- 0864US7514429B2Benzoxazinone-derived compounds, their preparation and use as medicamentsESTEVE LAB DR ESTEVE S A·Filed 2006·Granted Apr 7, 2009·1 cites·7 claims
- 0958US7662862B25-HT7 receptor antagonistsESTEVE LABOR DR·Filed 2009·Granted Feb 16, 2010·0 cites·8 claims
- 1054US7056914B2Benzoxazinone-derived compounds, their preparation and use as medicamentsESTEVE LAB DR ESTEVE S A·Filed 2003·Granted Jun 6, 2006·1 cites·32 claims
- 1150US2010197939A1Process for the enantioselective preparation of pregabalinESTEVE LABOR DR·Filed 2008·Application pending·0 cites
- 1250US2007059364A1Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinityESTEVE LABOR DR·Filed 2004·Application pending·0 cites
- 1348US2011092540A1Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligandsESTEVE LABOR DR·Filed 2009·Application pending·0 cites
- 1445US7928121B25-HT7 receptor antagonistsESTEVE LABOR DR·Filed 2005·Granted Apr 19, 2011·0 cites·10 claims
- 1544US2007009597A1Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinityESTEVE LABOR DR·Filed 2004·Application pending·0 cites
- 1644US2009247771A1Process for obtaining enantiomers of duloxetine precursorsBUSCHMANN HELMUT HEINRICH·Filed 2007·Application pending·0 cites
- 1743US2010280072A12-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesityESTEVE LABOR DR·Filed 2010·Application pending·0 cites
- 1843US2007032471A1Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulatorESTEVE LABOR DR·Filed 2004·Application pending·0 cites
- 1942US2012128768A1Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinityTORRENS JOVER ANTONI·Filed 2012·Application pending·0 cites
- 2040US7553965B25-HT7 receptor antagonistsESTEVE LABOR DR·Filed 2005·Granted Jun 30, 2009·0 cites·30 claims
- 2140US2007032482A1Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicamentsESTEVE LABOR DR·Filed 2004·Application pending·0 cites
- 2238US8148397B25-HT7 receptor antagonistsTORRENS JOVER ANTONI·Filed 2005·Granted Apr 3, 2012·0 cites·10 claims
- 2337US2006142589A1Process for obtaining enantiomers of CizolirtineTORRENS JOVER ANTONI·Filed 2005·Application pending·0 cites
- 2424US9181195B2Sigma receptor inhibitorsGARCÍA LÓPEZ MÓNICA·Filed 2011·Granted Nov 10, 2015·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Antoni Torrens Jover files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →